We are live on
!
Find out more
Level Four Advisory Services Portfolio holdings
AUM
$3.54B
Turnover
13.95%
1-Year Est. Return
37.12%
This Fund
S&P 500
This Quarter
Est. Return
+2.12%
1 Year Est. Return
+37.12%
3 Year Est. Return
+92.23%
5 Year Est. Return
+115.57%
10 Year Est. Return
–
AUM
$2.22B
AUM Growth
+$398M
(+22%)
Cap. Flow
+$244M
Cap. Flow
% of AUM
11%
Top 10 Holdings %
Top 10 Hldgs %
22.6%
Holding
921
New
146
Increased
308
Reduced
277
Closed
180
Avg Time Held Equity + Options
3.1
years
Top 10 Avg Time Held Equity + Options
2.1
years
Top 20 Avg Time Held Equity + Options
2.1
years
Avg Time Held Equity only
3.1
years
Top 10 Avg Time Held Equity only
2.1
years
Top 20 Avg Time Held Equity only
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T. Rowe Price Capital Appreciation Equity ETF
TCAF
|
+$18.6M |
| 2 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$17.3M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$17M |
| 4 |
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$14.4M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$10.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$11M |
| 2 |
Gentex
GNTX
|
+$10.4M |
| 3 |
Fidelity Total Bond ETF
FBND
|
+$10.4M |
| 4 |
State Street SPDR Portfolio Europe ETF
SPEU
|
+$10.2M |
| 5 |
Vanguard Total Bond Market
BND
|
+$9.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.72% |
| 2 | Technology | 18.83% |
| 3 | Financials | 7.73% |
| 4 | Consumer Discretionary | 6.97% |
| 5 | Healthcare | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
351
Trane Technologies
TT
$101B
| $928K | 0.04% |
2,822
+65
| +2% | +$20.7K |
2022 Q4
6 quarters
|
|
352
Chord Energy
CHRD
$8.11B
| $928K | 0.04% |
+5,533
| New | +$982K |
2024 Q2
0 quarters
|
|
353
Bristol-Myers Squibb
BMY
$124B
| $927K | 0.04% |
22,322
-4,070
| -15% | -$182K |
2016 Q4
30 quarters
|
|
354
HCA Healthcare
HCA
$101B
| $919K | 0.04% |
2,861
+403
| +16% | +$131K |
2020 Q2
16 quarters
|
|
355
Standex International
SXI
$3.28B
| $918K | 0.04% |
+5,694
| New | +$963K |
2024 Q2
0 quarters
|
|
356
Invesco S&P 500 Revenue ETF
RWL
$10.2B
| $917K | 0.04% |
9,895
-10,754
| -52% | -$987K |
2023 Q2
4 quarters
|
|
357
Edwards Lifesciences
EW
$50.8B
| $916K | 0.04% |
9,916
+1,598
| +19% | +$142K |
2023 Q4
2 quarters
|
|
358
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.2B
| $912K | 0.04% |
11,685
-13,493
| -54% | -$1.02M |
2022 Q4
6 quarters
|
|
359
Cars.com
CARS
$548M
| $897K | 0.04% |
+45,531
| New | +$831K |
2024 Q2
0 quarters
|
|
360
Boeing
BA
$149B
| $885K | 0.04% |
4,864
-3,360
| -41% | -$599K |
2016 Q4
30 quarters
|
|
361
iShares Morningstar Mid-Cap Value ETF
IMCV
$1.16B
| $884K | 0.04% |
12,585
+3
| +0% | +$212 |
2016 Q4
30 quarters
|
|
362
Pembina Pipeline
PBA
$28B
| $878K | 0.04% |
23,685
-90
| -0.4% | -$3.25K |
2016 Q4
30 quarters
|
|
363
First Trust Health Care AlphaDEX Fund
FXH
$1.17B
| $872K | 0.04% |
8,342
+75
| +0.9% | +$7.88K |
2016 Q4
30 quarters
|
|
364
Copart
CPRT
$25.7B
| $870K | 0.04% |
+16,057
| New | +$877K |
2024 Q2
0 quarters
|
|
365
HF Sinclair
DINO
$22.2B
| $868K | 0.04% |
16,270
-2,574
| -14% | -$145K |
2021 Q1
13 quarters
|
|
366
Acuity Brands
AYI
$9.04B
| $861K | 0.04% |
+3,568
| New | +$912K |
2024 Q2
0 quarters
|
|
367
First Trust Technology AlphaDEX Fund
FXL
$2.82B
| $861K | 0.04% |
6,318
-179
| -3% | -$23.6K |
2016 Q4
30 quarters
|
|
368
Vanguard Short-Term Corporate Bond ETF
VCSH
$44B
| $860K | 0.04% |
11,134
+260
| +2% | +$20K |
2021 Q4
10 quarters
|
|
369
Alerian MLP ETF
AMLP
$12.5B
| $860K | 0.04% |
17,915
+334
| +2% | +$15.6K |
2022 Q4
6 quarters
|
|
370
Xylem
XYL
$24.1B
| $858K | 0.04% |
+6,324
| New | +$860K |
2024 Q2
0 quarters
|
|
371
Cboe Global Markets
CBOE
$32.2B
| $858K | 0.04% |
+5,042
| New | +$895K |
2024 Q2
0 quarters
|
|
372
Avantis US Equity ETF
AVUS
$14.7B
| $852K | 0.04% |
9,450
| – | – |
2023 Q4
2 quarters
|
|
373
Enbridge
ENB
$104B
| $847K | 0.04% |
23,802
-5,868
| -20% | -$210K |
2016 Q4
30 quarters
|
|
374
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
| $839K | 0.04% |
17,223
-106,757
| -86% | -$5.22M |
2020 Q1
17 quarters
|
|
375
Western Union
WU
$1.94B
| $833K | 0.04% |
+68,192
| New | +$886K |
2024 Q2
0 quarters
|
|
Similar funds
Level Four Advisory Services's Q2 2024 Portfolio in Review
As of Q2 2024, Level Four Advisory Services held 921 positions worth $2.22B, up 22% from $1.82B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Level Four Advisory Services deployed $244M of net new capital in Q2 2024, opening 146 new positions and adding to 308 existing holdings. Its largest new stake was T. Rowe Price Capital Appreciation Equity ETF: 614,289 shares worth $19.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, down from 42% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $11M trimmed.
- Level Four Advisory Services's largest Q2 2024 buy was T. Rowe Price Capital Appreciation Equity ETF: 614,289 shares worth $19.3M.
- Level Four Advisory Services added most to JPMorgan International Research Enhanced Equity ETF in Q2 2024, an estimated $17.3M increase.
- Level Four Advisory Services's biggest Q2 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $11M.
- Level Four Advisory Services fully exited Gentex in Q2 2024, selling an estimated $10.4M.
- Level Four Advisory Services's ten largest holdings make up 23% of its $2.22B portfolio in Q2 2024.
- Level Four Advisory Services opened 146 new positions and closed 180 in Q2 2024.
- Level Four Advisory Services's portfolio value rose 22% quarter-over-quarter to $2.22B.
Based on Level Four Advisory Services's 13F filing for Q2 2024, filed 9 Aug 2024.